SCHEMBL6788461

SCHEMBL6788461

O=C(O)C(Sc1ccc(O)cc1)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
HSD17B10 Q99714 1/20 0.56
MAPK1 P28482 1/20 0.43
MMP2 P08253 1/20 0.42
MMP8 P22894 1/20 0.42
MMP14 P50281 1/20 0.42
PPARA Q07869 1/20 0.40
MMP1 P03956 1/20 0.39
TSHR P16473 1/20 0.39
SRC P12931 1/20 0.39
TRPA1 O75762 1/20 0.38
LMNA P02545 3/20 0.38
THRB P10828 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
PLA2G1B P04054 1/20 0.38
NPY1R P25929 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3521016 0.93 CYP2C9 (0.63) CYP2C9CYP2C19HSD17B10MMP2MMP8
SCHEMBL28703755 0.86 CYP2C9 (0.59) CYP2C9CYP2C19HSD17B10MAPK1MMP2
SCHEMBL11563095 0.86 CYP2C9 (0.55) CYP2C9CYP2C19HSD17B10MAPK1PPARA
SCHEMBL11562132 0.86 CYP2C9 (0.59) CYP2C9CYP2C19HSD17B10MAPK1MMP2
SCHEMBL933757 0.85 CYP2C9 (0.54) CYP2C9CYP2C19HSD17B10MMP2MMP8
SCHEMBL933879 0.85 CYP2C9 (0.54) CYP2C9CYP2C19HSD17B10MMP2MMP8
SCHEMBL6658202 0.83 MEN1 (0.40) CYP2C9CYP2C19HSD17B10SRCLMNA
SCHEMBL6782198 0.83 MEN1 (0.45) CYP2C9CYP2C19HSD17B10SRCLMNA
SCHEMBL11761904 0.81 TRPA1 (0.51) CYP2C9CYP2C19HSD17B10TRPA1LMNA
SCHEMBL7321447 0.81 MEN1 (0.43) CYP2C9CYP2C19HSD17B10MAPK1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825354-B2 OSTEOPOROSIS; RHEUMATIC DISEASES WYETH HOLDINGS CORPORATION 2004-11-30 US disclosed
US-6340691-B1 TREATMENT OF ARTHRITIS, TUMOR METASTASIS, TISSUE ULCERATION, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, DIABETES (INSULIN RESISTANCE) AND HIV INFECTION AMERICAN CYANAMID COMPANY 2002-01-22 US disclosed